Why the study?
Although an invasive strategy for NSTEMI is recommended for the general population, its benefit and necessity remain unclear in heterogeneous octogenarian patients due to comorbidities, frailty, and procedural risks.
Does an invasive strategy improve clinical outcomes in octogenarians with NSTEMI compared to a conservative strategy?
Population
Octogenarians presenting with non-ST-segment elevation acute myocardial infarction, including frail and…
Comparison
Invasive strategy vs Conservative strategy (medical management)
Design
Review
Authors
Loading...
Individualized risk stratification may optimize care in heterogeneous octogenarian ACS patients; leaves open optimal invasive thresholds pending dedicated trials.
Does an invasive strategy improve clinical outcomes in octogenarians with NSTEMI compared to a conservative strategy?
The decision to pursue an invasive strategy in octogenarians with NSTEMI requires individualized assessment of frailty, comorbidities, and bleeding risk rather than relying on age alone.
Álvarez-Zaballos et al. (2024) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: